在黑色素瘤中,可能通过α-synuclein调节免疫调节剂拉斯班CD81的调节

Nirjhar M Aloy1, Christina Coughlan2, Michael W Graner2

  • 1Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, LA, USA; Feist-Weiller Cancer Center, Louisiana State University Health Shreveport, Shreveport, USA.

概括

帕金森病的蛋白质α-synuclein (α-syn) 通过增加CD81水平,促进细胞入侵和免疫抑制,驱动黑色素瘤的进展. 这导致更具侵略性的瘤和更差的生存率.